Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuation of oral anticoagulants during dental extraction
ACTRN12615001009505Phase 4Recruiting
- Sponsor
- Dr Jennifer Curnow
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dabigatran, rivaroxaban, apixaban and warfarin in anticoagulant therapy (2 arms), sponsored by Dr Jennifer Curnow. Primary endpoint: Immediate post-extraction blood loss. Started Feb 2016; status: recruiting.
02
Drugs
dabigatranrivaroxabanapixabanwarfarin
03
Conditions
anticoagulant therapy
Beyond the preview
Go deeper on ACTRN12615001009505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001009505.